Bristol-Myers Squibb to Take Part at the Wolfe Research Healthcare Conference

NEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) will take part in a fireside chat at the Wolfe Research Healthcare Conference on Wednesday, November 6, 2019, in New York. Giovanni Caforio, M.D., chairman and chief executive officer will answer questions at 3:10 p.m. ET.

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. Materials related to the presentation will be available at the same website at the start of the live webcast. An archived edition of the session will be available later that day.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

View source version on businesswire.com: https://www.businesswire.com/news/home/20191030006014/en/

Media: Carrie Fernandez, 609-252-5222, [email protected]

Investors: Tim Power, 609-252-7509, [email protected]

Source: Bristol-Myers Squibb Company

You May Also Be Interested In

• Primemas Shatters AI Memory Wall at FMS 2026 with CXL Full-Stack Products and Micron Collaboration on the Abaco Project
• Best’s Market Segment Report: Asia-Pacific Reinsurers Show Resilience Amid Evolving Market Landscapes
• LayerZero (ZRO) Has Deployed $112M Into Buybacks, Next Crypto To Explode Could Be AlphaPepe With $2.5M Raised